top of page

Free Biopharma Daily Stock Updates - 04/22/21

$XBI $134 +2%

 

Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!

 

Pipeline Updates

$TRIL -5% Will host investor day 4/18. Clinical updates for TTI-622 and TTI-621, updated 2021 milestones and guidance. source


$CDAK +35% Preclinical data published in Communications Biology. source


$RDUS +9% Business update, Q1 patient numbers, expected catalyst date on track for H2 2021. source


$AMRN +2% Great Britain approval of Vazkepa. source


$NOVN +20% to present ph 3 data at SID meeting May 3-8, 2021. source


$ZGNX -1% Presented new data at AAN meeting for Fintepla for LGS. source


$ONTX +25% First patient dosed in ph 2 study of rigosertib in SCC. source


$OCGN +43% Covid data

$BTX + 40%

$ALDX -10%


Finance Updates

$EOLS -18% Offering. source


$GKOS +1% Amendment to licensing agreement for topical eyelid delivery platform to include presbyopia. source


$MNOV +1% Received 2 milestone payments totaling $4 million for clinical development of gene therapy product based on AAV. source


$KMPH +1% Receives $10 million from milestone payment for FDA approval of Azstarys from Gurnet Point Capital per license agreement. source

0 comments

Comments


bottom of page